Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01928303 · ClinicalTrials.gov registry record
Predicting Oxycodone Dose From Oral Fluid Drug Levels
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 55
- Enrollment target
NCT01928303 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 55 participants.
The verdict
NCT01928303 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
This study will develop and test an algorithm that will estimate drug dosage from drug levels measured in oral fluid (saliva). Traditionally, urine has been used as the principle medium to monitor drug compliance in patients receiving opioids for chronic pain as well as those being treated for substance abuse. Recently, the use of saliva as an alternative to urine drug testing has been gaining in popularity. Oral fluid has several advantages over urine as a medium for drug screening. In this study, oral fluid, urine and blood specimens will be collected from volunteer patient donors with chronic pain taking opioid medications. Samples from the anonymous donor will be analyzed for opiate class drugs, using New York State Department of Health approved and validated laboratory methods. Analytical results and other information collected will assist in evaluating the use of oral fluid as a specimen to detect opiate drug levels. The measurement of drug concentrations in blood and oral fluid simultaneously will allow for the determination of the amount of oral fluid that will be needed for successful drug testing. It is proposed that by measuring oral fluid drug levels an estimate of the amount of drug taken will be possible.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01928303
The ClinicalTrials.gov registry entry for NCT01928303 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01928303 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01928303 about?
NCT01928303 is a clinical study titled "Predicting Oxycodone Dose From Oral Fluid Drug Levels". This study will develop and test an algorithm that will estimate drug dosage from drug levels measured in oral fluid (saliva). Traditionally, urine has been used as the principle medium to monitor drug compliance in patients receiving opioids for chronic pain as well as those being treated for subst...
What is the current status of trial NCT01928303?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2013-03. Estimated completion is 2014-08.
Who is sponsoring clinical trial NCT01928303?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.